drugset / Trial / NCT01265732
A Comparison Of The Pharmacokinetics Of PF-04191834 Following Single Dose Administration Of A Dispersion Formulation And A Suspension Formulation In Healthy Volunteers
RandomizedCrossoverOpen-labelBasic science
Summary
This study investigates the safety, tolerability and pharmacokinetics of PF-04191834 when respectively given orally as a single dispersion dose and a single dose of a suspension. The suspension is the test formulation and the dispersion is the formulation with which the novel preparation will be compared.
Timeline
- Start
- 2010-12
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | PF-4191834 | Small molecule | 100 mg | Oral |
| Comparator | PF-4191834 | Small molecule | 300 mg | Oral |
Indications
No indication recorded.